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We are using directed evolution to extend the range of dioxygenase-catalyzed biotransformations to include
substrates that are either poorly accepted or not accepted at all by the naturally occurring enzymes. Here we
report on the oxidation of a heterocyclic substrate, 4-picoline, by toluene dioxygenase (TDO) and improvement
of the enzyme’s activity by laboratory evolution. The biotransformation of 4-picoline proceeds at only ;4.5%
of the rate of the natural reaction on toluene. Random mutagenesis, saturation mutagenesis, and screening di-
rectly for product formation using a modified Gibbs assay generated mutant TDO 3-B38, in which the wild-type
stop codon was replaced with a codon encoding threonine. Escherichia coli-expressed TDO 3-B38 exhibited 5.6
times higher activity toward 4-picoline and ;20% more activity towards toluene than wild-type TDO. The prod-
uct of the biotransformation of 4-picoline is 3-hydroxy-4-picoline; no cis-diols of 4-picoline were observed.
Dioxygenase enzymes involved in the catabolism of aromatic
hydrocarbons by soil microorganisms nicely illustrate nature’s
ability to adapt to different carbon sources through evolution
of the substrate specificity of the biodegradation enzymes (35).
The biodegradation pathway often begins with the dioxygenase-
catalyzed regio- and enantio-specific introduction of molecular
oxygen into aromatic compounds to form the corresponding
arene cis-diols, with consumption of NADH (13, 36) (Fig. 1).
It has been noted that the chiral products of the dioxygenase
reaction can be converted in a variety of synthetic reactions to
advanced intermediates for natural-product synthesis (8, 15).
Toluene dioxygenase (TDO) from Pseudomonas putida readily
dihydroxylates aromatic carbocycles with one or two small hy-
drophobic substituents (6, 33). Activity towards much larger,
fused-ring substrates or substrates with polar or bulky substitu-
ents is considerably reduced or nonexistent (33).
We are attempting to extend the utility of dioxygenase-cat-
alyzed biotransformations by engineering the catalysts to
accept a wider range of substrates, including small hetero-
cyclic compounds and polar-substituted carbocyclic aromatics.
N-Heterocyclic compounds are useful for the synthesis of bio-
logically active compounds; recent reports describe the regio-
and/or stereo-controlled biooxidation of N-heterocycles (20,
26). Bicyclic compounds such as quinolines and benzofurans
are accepted by TDO, with oxygen insertion occurring primar-
ily in the carbocylic rings (3–5).
To date, reactions on single-ring heterocycles have not been
reported. We have found that TDO catalyzes the oxygenation
of 4-picoline (4-methylpyridine), although at a much slower
rate than on its preferred substrate toluene.
A strategy of DNA shuffling to create libraries of hybrid
genes and screening has been used with some success to extend
the substrate range of dioxygenases that degrade environmen-
tal pollutants such as polychlorinated biphenyls (7, 21). An
alternative approach is to fine tune a single gene by accumulat-
ing beneficial mutations identified by screening randomly mu-
tated libraries (1). We have used this latter approach to inves-
tigate how readily TDO adapts to the heterocyclic substrate
4-picoline.
MATERIALS AND METHODS
Materials. Toluene was from Fisher Scientific (Pittsburgh, Pa.). Isopropyl-b-
D-thiogalactopyranoside (IPTG) was from ICN Biomedicals (Aurora, Calif.).
4-Picoline and 2,6-dichloroquinone chloroimide (Gibbs reagent) were from Al-
drich (Milwaukee, Wis.). Bugbuster was purchased from Novagen (Madison,
Wis.). NuPAGE materials, SeeBlue plus 2 size markers, and Novex colloidal blue
stain kit were purchased from Invitrogen (Carlsbad, Calif.). Ambersorb XEN-
575 and ampicillin were from Sigma (St. Louis. Mo.). cis-(1S,2R)-Dihydroxy-3-
methylcyclohexa-3,5-diene (cis-toluene dihydrodiol) was purchased from QuChem
(Belfast). Plasmid pTrc99A was from Amersham Pharmacia Biotech (Piscataway,
N.J.). Restriction enzymes were from New England Biolabs (Beverly, Calif.), and
T4 DNA ligase was from Roche Diagnostics (Indianapolis, Ind.). Amplitaq DNA
polymerase was purchased from Perkin-Elmer (Norwalk, Conn.), and Pfu DNA
polymerase was from Stratagene (La Jolla, Calif.). The 96-well plates were pur-
chased from Rainin (Emeryville, Calif.).
Bacterial strains and plasmids. E. coli DH5a and BL21(DE3) were used for
cloning and expression, respectively. pDTG601 carrying the todC1C2BA cistron
was kindly provided by D. T. Gibson (37). A 2.2-kbp DNA fragment including
todC2BA was PCR amplified using primers TDO9F (59-TTGGATCCGGTGG
ACCTTGTCCATTTG-39) and TDO10R (59-GCTCTAGATCACGTTAGGTC
TCCTTCATTCG-39) and cloned into the BamHI and XbaI sites of pTrc99A to
yield plasmid pXTD8. Primers TDO12F (59-CGGAATTCTAGGAAACAGAC
CATG-39) and TDO13R (59-CCGGATCCAACCTGGGTCGAAGTCAAATG-
39) were used for PCR amplification of a 1.4-kbp DNA fragment carrying todC1,
with substitution of a ribosome-binding-site sequence (GAGAA) with a se-
quence (AGGAA) designed for higher expression of todC1. Following double
digestion with EcoRI and BamHI, the DNA fragment was ligated to pXTD8
double-digested with EcoRI and BamHI, which yielded plasmid pXTD12 (wild
type).
Random mutagenesis of todC1. Error-prone PCR was used to introduce mu-
tations into the todC1 structural gene and 45 downstream nucleotides. Reaction
mixture (50 ml) contained 66.5 pg of pXTD12 (wild type), 20 pmol each of
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primers TDO12F and TDO13R, 100 nmol of each deoxynucleoside triphosphate
(dNTP), 350 nmol of MgCl2, 30 nmol of MnCl2, and 1.25 U of AmpliTaq DNA
polymerase. PCR was carried out with an MJ research PTC-200 thermal cycler
(Watertown, Mass.) under the following conditions: 3 min at 94°C, 30 cycles of
30 s at 94°C, 30 s at 50°C, and 1 min at 72°C, and 3 min at 72°C. Following double
digestion of the PCR product, the resulting DNA fragment was ligated back to
pXTD8 at the EcoRI and BamHI sites.
Saturation mutagenesis. To minimize point mutations, Pfu DNA polymerase
was used in the following PCR. A 50-ul PCR mixture contained 0.5 ng of
template DNA, 20 pmol of each primer, 10 nmol of each dNTP, and 1.25 U of
Pfu DNA polymerase. PCR was performed using an MJ research PTC-200
thermal cycler as follows: 3 min at 94°C, 30 cycles of 30 s at 94°C, 30 s at 50°C,
and 2 min at 72°C, and 5 min at 72°C. Two degenerate primers, TDO32F
(59-AAGGCGACANNNNNNATCCAGAGACAG-39) and TDO33R (59-TCTC
TGGATNNNNNNTGTCGCCTTCAG-39) were designed to randomize posi-
tions 450 and 451 in the amino acid sequence (Arg and stop codons in the
wild-type DNA sequence). Plasmid DNA was purified from mutants 8A (con-
taining mutation c1242t) and 16A (containing mutations t1351c and g1376t). An
equimolar mixture served as the template in the following two-step saturation
mutagenesis. In the first step, the first 1,400 nucleotides of todC1 were amplified
by PCR using primers TDO12F and TDO33R, and in the second step, 100
nucleotides were amplified using primers TDO32F and TDO13R. After the
second step, the two PCR products were combined at a 1:1 molar ratio and used
as the template in a PCR using TDO12F and TDO13R to obtain the full-length
todC1 fragment. This product, which contains randomized positions and recom-
binations of the mutations in 8A and 16A, was cloned back into pXTD8 to
produce a second-generation mutant library of todC1. Screening of ;2,200
clones on 4-picoline identified seven higher-activity clones. An equimolar-ratio
mixture of plasmid DNA from those seven was used for saturation mutagenesis
at amino acid position 352. Two degenerate primers, TDO34F (59-CTGATGC
TCCTNNSGATATCAAGA-39) and TDO35R (59-CTTGATATCSNNAGGAG
CATCA-39) were designed to randomize this position. The two-step PCR was
performed as described above, and todC1 fragments obtained were cloned into
pXTD8 to produce the third-generation mutant todC1 library.
Screening procedure. An aliquot of the ligation mixture was used to transform
E. coli BL21(DE3) by the CaCl2 method (29). At the same time, two control
plasmids, pXTD12 (wild type) as a positive control and pXTD8 as a negative
control, were used to transform E. coli BL21(DE3) separately. Transformants
were grown on Luria-Bertani (LB) agar plates (29) containing ampicillin (100
mg/ml) at 37°C. Each colony was inoculated into 100 ml of LB medium containing
ampicillin (100 mg/ml) in separate wells of a 96-well plate. Each 96-well plate
accommodated 94 mutants plus one positive and one negative control. Plates
were shaken at 270 rpm at 37°C overnight with a New Brunswick Scientific
Innova 4000 incubator shaker (Edison, N.J.), and 10 ml of the culture was
transferred to new wells containing 100 ml of M9 medium (29) supplemented
with 0.4 % glucose, 0.5 mM IPTG, and ampicillin (100 mg/ml). Following 5 h of
incubation at 30°C, the culture was mixed with reaction medium containing 50
mM sodium phosphate buffer (pH 7.4), 0.2% glucose, and toluene or 4-picoline
to give a final concentration of 5 mM substrate and a total volume of 100 ml.
Biotransformation was carried out at room temperature for 30 min (toluene) or
1 h (4-picoline).
A Beckman Instruments Multimek 96 automated multichannel pipettor (Ful-
lerton, Calif.) was used for liquid handling in the following protocol. Activities
were determined by adding 100 ml of 0.1 M HCl to 100 ml of biotransformation
mixture to reduce the pH below 3.0. Following centrifugation at 1,700 3 g for
5 min, 100 ml of supernatant was removed and incubated at 37°C for 30 min.
Then, 20 ml of 1 M Tris-HCl buffer (pH 8.5) was added, followed by 25 ml of
0.4% Gibbs’ reagent ethanol solution. Absorbance was measured at 590 nm for
toluene or 600 nm for 4-picoline with a Molecular Devices Spectramax 250 plate
reader (Sunnyvale, Calif.) after blue color developed.
Scaled-up biotransformation. A New Brunswick Scientific Innova 4000 incu-
bator shaker was used for shaking in the following cultivation and biotransfor-
mation. Frozen cell culture of E. coli BL21(DE3) carrying the plasmid in ques-
tion (10 ml) was inoculated into 1 ml of LB medium containing ampicillin (100
mg/ml) and shaken overnight at 270 rpm at 37°C. Then 250 ml of the resulting
seed culture was transferred into 25 ml of fresh medium in a 250-ml flask and
shaken at 270 rpm at 37°C. When the optical density at 600 nm of the culture
reached 0.5 to 0.7, 100 mM IPTG was added to a final concentration of 1 mM.
At this point, the growth temperature was shifted to 30°C and incubation pro-
ceeded for an additional 3 h. Then 2.5 ml of the culture was removed into a test
tube, and cells were spun down at 1,700 3 g for 5 min. Collected cells were
washed once with 2.5 ml of 50 mM sodium phosphate buffer (pH 7.4) and
suspended with 10 ml of reaction medium containing 50 mM sodium phosphate
buffer (pH 7.4) and 0.2% glucose. Biotransformation was started by adding
substrate to a final concentration of 5 mM. The mixture was shaken at 270 rpm
at 30°C, and 100 ml of sample was removed every 30 min for 1.5 h. Product
accumulation was monitored using the Gibbs assay, as described above for
high-throughput screening.
Protein extraction and expression analysis of mutant clones. Frozen cell
cultures of BL21(DE3) carrying mutant plasmids were grown and induced ac-
cording to the conditions of the scaled-up biotransformation. After induction
with 1 mM IPTG, 20 ml of cells was spun down at 2,060 3 g for 10 min and
resuspended in 1.5 ml of Bugbuster protein extraction reagent. The cells were
broken with shaking at room temperature for 15 min. Insoluble cell debris was
removed by centrifugation at 20,200 3 g for 20 min at 4°C, and the cell extract
was removed to a fresh tube.
To 13 ml of cell extract was added 13 ml of water, 10 ml of NuPAGE lithium
dodecyl sulfate sample buffer, and 4 ml of NuPAGE sample reducing agent. The
sample was heated for 10 min at 70°C, and 10 ml was loaded into a NuPAGE 10%
Bis-Tris gel (1.0 mm 3 15) and run according to the manufacturer’s instructions.
As a size standard, 10 ml of SeeBlue Plus 2 was added to two wells. The gel was
stained using the Novex colloidal blue stain kit.
Purification and identification of biotransformation product. Biotransforma-
tion of 4-picoline was carried out with E. coli BL21(DE3) expressing wild-type
FIG. 1. TDO system. TDO catalyzes the insertion of molecular oxygen into toluene and 4-picoline to form toluene cis-dihydrodiol and
3-hydroxy-4-picoline, respectively, with consumption of NADH.
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TDO. The oxygenated product was bound to Ambersorb XEN-575 (11) and
eluted into ethyl acetate-ethanol. (1:1, vol/vol). The concentrated sample was
subjected to silica gel column (2.5 by 30 cm) chromatography. The product was
eluted with hexane-acetone (1:1, vol/vol), and fractions containing the product,
as determined by the Gibbs assay, were collected. Solvent was removed by
evaporation, and the product was obtained as slightly yellow crystals.
Analytical. The fragmentation pattern of the biotransformation product was
obtained with a Hewlett-Packard HP5890 series II gas chromatograph and an
HP5989A mass spectrometer (Palo Alto, Calif.) equipped with a Quadrex 007-1,
0.1-mm-thickness dimethylpolysiloxane phase (0.18 mm diameter by 3 m) column
(Woodbridge, Conn.) 1H nuclear magnetic resonance (NMR) spectra were ob-
tained with a Varian, Inc., Mercury 300-MHz NMR spectrometer (Palo Alto,
Calif.) on samples dissolved in chloroform-d (minimum 99.8%).
RESULTS AND DISCUSSION
Biooxidation of 4-picoline by E. coli BL21(DE3) expressing
TDO. Biotransformation using TDO is performed in a whole-
cell system because the enzyme comprises multiple compo-
nents and requires cofactor regeneration (13). Recombinant
E. coli cells expressing TDO accumulate relatively large
amounts of the biocatalyst and do not have any cis-diol-de-
grading activity. In a system such as this, total activity is the
important figure of merit and reflects the catalyst expression
level as well as specific activity.
Gas chromatography-mass spectroscopy (GC-MS) of the
product of TDO-catalyzed biotransformation of 4-picoline by
E. coli BL21(DE3) cells showed a molecular mass (109 D) and
fragmentation pattern indicative of hydroxypicoline. The 1H-
NMR spectrum of 2-hydroxy-4-picoline, with peaks at 2.23
ppm (s, 3H), 6.13 ppm (dd, J 5 6.7 Hz, 1.6 Hz, 1 H), 6.38 ppm
(m, J 5 0.8 Hz, 1 H) and 7.25 ppm (d, J 5 7.0 Hz, 1 H), differs
from that of the product, 2.33 ppm (s, 3H), 7.15 ppm (d, J 5
4.8 Hz, 1 H), 7.98 ppm (d, J 5 4.8 Hz, 1 H), and 8.24 ppm
(s, 1 H), which we have identified as 3-hydroxy-4-picoline.
cis-Dihydrodiols of 4-picoline were not detected either by
NMR or by GC-MS analysis of the ethyl acetate extract.
Formation of the monohydroxylated product 3-hydroxy-4-
picoline likely involves an unstable cis-dihydrodiol which un-
dergoes spontaneous dehydration, as has been proposed to
explain the formation of indigo from indole (9), the metabo-
lism of 4-nitrotoluene (28), and analogous monohydroxylated
products of the TDO-catalyzed oxidation of quinolines (5).
With an initial rate of product formation of 0.22 mmol of
3-hydroxy-4-picoline/h/g of dried cells, TDO is ;4.5% as active
on the heterocyclic substrate as it is towards toluene (5.1 mmol
of toluene cis-dihydrodiol/h/g of dried cells). The polar nitro-
gen-containing heterocycle is not transformed as efficiently as
are other nonnatural TDO substrates, such as aromatics with
bulky substituents and aliphatic olefins (12, 22, 33)
Directed evolution of TDO. Oxygenase activity is often de-
termined by monitoring consumption of exogenously added
NADH (16). We chose, however, to monitor product forma-
tion directly, as we expect mutant TDOs to participate in un-
coupling reactions (23) to different extents. The Gibbs reaction
has been used for detection of dioxygenase activity (27), but
the reported protocol was not sensitive enough to differentiate
the small changes in product levels expected during directed
evolution. With acid treatment prior to the Gibbs reaction (to
catalyze cis-dihydrodiol dehydration to the corresponding phe-
nol) and other modifications, we established a liquid assay
system ;20 times more sensitive than that reported previously
(19). A solid-phase version of the assay was also described (19).
This assay is suitable for monitoring production of 3-hydroxy-
4-picoline. Although this product can be detected without the
acidification step, reducing the pH significantly lowers the back-
ground absorption that arises from contaminants in the culture
medium. We therefore retained this step while screening mu-
tants for activity towards 4-picoline.
Because random mutagenesis of an enzyme as large as TDO
(637 amino acids) generates a large number of potential mu-
tants, it is desirable to target the mutagenesis to sequences that
are most likely to affect substrate specificity. TDO substrate
specificity is determined by the terminal oxygenase, ISPTOL,
which is composed of a larger a subunit and a smaller b subunit
(30–32). The a subunit accommodates the Rieske [2Fe-2S] center
and the mononuclear iron necessary for catalytic activity and
appears to play a major role in determining substrate specific-
ity (2, 7, 10, 25, 34), whereas the b subunit is proposed to have
only a structural role (18). Although the b subunit of ISPTOL
might also affect interactions with substrate (14, 17), we target-
ed only the a subunit in this initial study.
The first mutant library was generated by error-prone PCR
of the 1.4-kbp todC1 fragment encoding the a subunit of ISP-
TOL using 0.6 mM MnCl2. Screening ;1,000 members of this
library for activity on toluene showed ;20 to 30% inactivation
(Fig. 2), which in our experience corresponds to an optimal
mutation rate of 2 to 3 nucleotides per sequence. Subsequent
DNA sequencing of selected mutants in fact revealed 1 to 3
mutations per 1.4-kbp DNA fragment. We observed a heavy
bias for transitions over transversions (7 to 1), however, which
limits diversity at the amino acid level.
Important for validation of the screening method, the stan-
dard deviation of the activity measurement for screening wild-
type clones is small (4.5%) compared to the variation in activ-
ity in the mutant library (Fig. 2). One mutant, designated 3B,
exhibited significantly higher activity towards toluene than the
wild type. This mutant also proved superior in a scaled-up bio-
transformation of toluene (Table 1).
Approximately 9,000 clones from this library were screened
for high activity toward 4-picoline. Selected mutants were
tested in a 10-ml scale biotransformation, and those results are
summarized in Table 1. The best mutant, 16A, was 3.7 times
more active toward 4-picoline than wild-type TDO; activity
toward toluene increased 1.5-fold. DNA sequencing of 16A
and three different mutant TDOs which showed activity pro-
files similar to that of 16A revealed that the common substi-
FIG. 2. Activities of wild-type TDO and the first-generation mu-
tant TDO library. The activities of each wild-type TDO relative to the
average (shaded line) and that of mutant TDO relative to wild-type
TDO (black line) are plotted in descending order.
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tution of the stop codon (TGA) with Arg (CGA) at amino acid
position 451 conferred the improvement in total activity to-
ward 4-picoline and toluene.
The identical stop codon mutation was also observed in
mutant 3B, obtained during screening for activity on toluene.
Mutants 3B and 16A show the same activity towards toluene,
but the activity of 3B toward 4-picoline is only a fraction of that
of 16A. The difference in substrate specificity is attributed to
either or both of the additional amino acid substitutions in 3B,
F181L and I232V.
Synonymous mutation c1242t (in mutant 8A) and the non-
synonymous g1349a mutation in 6B (substitution of R450 by
H) and a1055g mutation in 12E (substitution of D352 by G) all
increase total activity but have no or little effect on substrate
specificity. The only mutation in 8A, c1242t, is located in the
middle of a CG stretch of 10 nucleotides. This mutation might
facilitate transcription of todC1 by destabilizing the DNA sec-
ondary structure.
Further evolution of TDO. Random mutagenesis highlighted
C-terminal positions 450 and 451 in the amino acid sequence
as contributing to the specificity and total activity of TDO. We
therefore used saturation mutagenesis to explore all possible
substitutions at these two consecutive codons. Using the strat-
egy described in Materials and Methods, we simultaneously
randomized the codons and recombined mutations c1242t (in
8A) and g1376t (in 16A). Seven superior clones were picked
out of 2,200 clones screened, and their plasmid mixture was
subjected to another round of saturation mutagenesis at codon
352 (at which 12E had a beneficial mutation). Screening ;600
clones identified three positive mutants, and the scale-up bio-
transformation tests revealed further improvements in activity
toward 4-picoline (Table 1).
E. coli BL21(DE3)-expressed mutant TDO 3B-38 exhibited
a 5.6-fold-enhanced initial reaction rate for oxidation of 4-pi-
coline (1.2 mmol of 3-hydroxy-4-picoline/h/g of dried cells) as
well as a slight increase in activity towards toluene (6.9 mmol
of toluene cis-dihydrodiol/h/g of dried cells) compared to wild-
type TDO. The product of TDO 3B-38 oxidation of picoline is
3-hydroxy-4-picoline, identical to the product of reaction with
wild-type TDO.
The results in Table 1 indicate a key role for amino acid 451
in determining activity towards 4-picoline. A proline or threo-
nine in place of arginine at this position increases activity
toward 4-picoline 1.5-fold, with no effect on activity toward
toluene. The preferred amino acid at 450 is either arginine
(wild type) or lysine. The saturation mutagenesis results also
show no particular benefit to be gained by substitution at po-
sition 352. Furthermore, the synonymous mutation, c1242t,
FIG. 3. SDS-PAGE comparison of cell extracts from mutant and wild-type strains. The lane labeled control contains an extract from
BL21(DE3) carrying pTrc99A, the empty vector used to construct the wild-type and mutant strains.
TABLE 1. Activities and mutations present in TDO variants
TDO
Amino acid
or codon at
position:
Additional
mutation(s)
Relative activity
(% of wild type)
6 SD
352 450 451 Toluene 4-Picoline
Wild type D R Stop 100 100
3B D R R F181L (t541c),
I232V (a694g)
140 6 10 45 6 3
6B D H Stop R450H (g1349a) 170 6 20 170 6 20
8A D R Stop [c1242t]a 190 6 20 170 6 20
12E G R Stop D352G (a1055g) 140 6 10 170 6 20
16A D R R R459L (g1376t) 150 6 10 370 6 30
3-A69 D K P 140 6 10 550 6 40
3-B38 D R T R459L (g1376t) 150 6 10 560 6 30
3-B61 P R P R459L (g1376t) 150 6 10 510 6 40
a Synonymous mutation.
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which conferred higher activity in 8A, was not retained in any
of the three highest-activity clones, indicating that it provides
no additional benefit in the presence of the stop codon muta-
tion.
Several of the mutants described in Table 1 were analyzed
by sodium dodecyl sulfate-polyacrylamide gel electrophoresis
(SDS-PAGE) (Fig. 3). For four variants containing the stop
codon mutation (16A, 3-A69, 3-B38, and 3-B61), the ISPTOL a
subunit (the large subunit) migrates as a slightly larger protein.
In addition, these variants showed dramatically increased ex-
pression of the b (smaller) subunit compared to variants with-
out the stop codon mutation. Presumably, the new stop codon
for todC1 in these variants appears just after the start codon of
todC2, which would extend the C terminus of the a subunit by
38 amino acids (Fig. 4). This type of overlapping gene structure
has also been reported to help expression of the subsequent
gene (24), as we have observed in this case for the b subunit.
Thus, mutation of the stop codon leads to extension of todC1
and a C-terminal extension of the protein which improve ac-
tivity toward 4-picoline by increasing expression and altering
the enzyme’s substrate specificity.
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